CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 75 filers reported holding CUE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,001 | -92.9% | 1,918 | -77.9% | 0.00% | -100.0% |
| Q4 2021 | $98,114 | -25.8% | 8,675 | -4.4% | 0.00% | -50.0% |
| Q3 2021 | $132,237 | +29.4% | 9,076 | +3.4% | 0.00% | +100.0% |
| Q2 2021 | $102,229 | +9.6% | 8,775 | +14.8% | 0.00% | 0.0% |
| Q1 2021 | $93,281 | -15.8% | 7,646 | -13.7% | 0.00% | -50.0% |
| Q4 2020 | $110,776 | -16.9% | 8,855 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $133,268 | -38.6% | 8,855 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $217,036 | +113.8% | 8,855 | +23.8% | 0.00% | +100.0% |
| Q1 2020 | $101,529 | -10.6% | 7,155 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $113,586 | – | 7,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |